The global Cancer Biopsy Market reached a value of USD 29.88 Billion in 2022 and is projected to achieve a revenue CAGR of 17% throughout the forecast period. A significant driver of this growth is the introduction of non-invasive biopsy techniques, like liquid biopsy, facilitated by advancements in diagnostic and imaging technology. In 2018, cancer ranked as the second leading cause of death...